Recent updates

Item amended Date Amended Amended Reason
3.12.1.2 Meaning of Pharmaceutical Substance

Content migration

3.12.1.1 Pharmaceutical Substance per se

Content migration

3.12.1 Section 70 Considerations

Content migration

3.12 Extension of Term of Standard Patents Relating to Pharmaceutical Substances

Content migration

3.11.4 Restoration of the Right of Priority under the PCT

Content migration

3.11.3.2.6 Parties Involved in Negotiations

Content migration

3.11.3.2.5 Period of Extensions to be Granted

Content migration

3.11.3.2.4 The Private and Public Interests

Content migration

3.11.3.2.3 Justification for the Extension

Content migration

3.11.3.2.2 Applicable Law

Content migration

3.11.3.2.1 Requests under Reg 5.10(2)

Content migration

3.11.3.2 Extensions under Reg 5.10(2)

Content migration

3.11.3.1 Extensions under Reg 5.10(1)

Content migration

3.11.3 Extensions of Time - Reg 5.10 (as in force immediately before 15 April 2013)

Content migration

3.11.2.9 "Out of Time" Evidence

Content migration

3.11.2.8 Review of a Decision to Grant or Refuse an Extension

Content migration

3.11.2.7 Parties Involved in Negotiations

Content migration

3.11.2.6 A Hearing in Relation to an Extension

Content migration

3.11.2.5 Period of an Extension

Content migration

3.11.2.4 Discretionary Matters

Content migration